11-β hydroxysteroid type 1 knockout mice display an antidepressant-like phenotype in the forced swim test

Acta Neuropsychiatrica

Volumn 28, Issue 1, 2015, Pages 55-60

  Slattery, David A ^a,b   Uzunov, Doncho P ^a   Cryan, John F ^a,c,d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

11 dehydroxysteroid dehydrogenase; corticosterone; knockout; mouse

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; GLUCOCORTICOID; HYDROXYSTEROID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; TAIL SUSPENSION TEST; ANIMAL; DEFICIENCY; ENZYMOLOGY; GENETICS; IMMOBILIZATION; METABOLISM; MOTOR ACTIVITY; PHENOTYPE; PHYSIOLOGY; PILOT STUDY; SWIMMING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; CORTICOSTERONE; DEPRESSIVE DISORDER; GLUCOCORTICOIDS; HINDLIMB SUSPENSION; HYDROXYSTEROIDS; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; PHENOTYPE; PILOT PROJECTS; SWIMMING;

EID: 84952875288     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2015.50     Document Type: Article

References (20)

1. HOLSBOER F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23:477-501.
2. PARIANTE CM, MILLER AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391-404.
3. YOUNG EA, CARLSON NE, BROWN MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 2001;25:267-276.
4. BREMMER MA, DEEG DJ, BEEKMAN AT, PENNINX BW, LIPS P, HOOGENDIJK WJ. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry 2007;62:479-486.
5. ISING M, KUNZEL HE, BINDER EB, NICKEL T, MODELL S, HOLSBOER F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1085-1093.
6. BORNSTEIN SR, SCHUPPENIES A, WONG ML, LICINIO J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006;11:892-902.
7. LI W, GAO L, WANG Y, DUAN T, MYATT L, SUN K. Enhancement of cortisol-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by interleukin 1beta in cultured human chorionic trophoblast cells. Endocrinology 2006;147:2490-2495.
8. PATERSON JM, SECKL JR, MULLINS JJ. Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice. Am J Physiol Regul Integr Comp Physiol 2005;289:R642-R652.
9. POOR V, BUFA A, BIRO I et al. Urinary steroid measurements in some endocrine and psychiatric diseases. Curr Med Chem 2005;12:1339-1342.
10. DEKKER MJ, TIEMEIER H, LUIJENDIJK HJ et al. The effect of common genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression. J Clin Endocrinol Metab 2012;97:E233-E237.
11. HARRIS HJ, KOTELEVTSEV Y, MULLINS JJ, SECKL JR, HOLMES MC. Intracellular regeneration of glucocorticoids by 11betahydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice. Endocrinology 2001;142:114-120.
12. WYRWOLL CS, HOLMES MC. Prenatal excess glucocorticoid exposure and adult affective disorders: a role for serotonergic and catecholamine pathways. Neuroendocrinology 2012;95: 47-55.
13. CRYAN JF, KELLY PH, NEIJT HC, SANSIG G, FLOR PJ, VAN DER PUTTEN H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 2003;17:2409-2417.
14. MOMBEREAU C, KAUPMANN K, FROESTL W, SANSIG G, VAN DER PUTTEN H, CRYAN JF. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxietyand antidepressant-like behavior. Neuropsychopharmacology 2004;29:1050-1062.
15. TOTH I, NEUMANN ID, SLATTERY DA. Social fear conditioning: a novel and specific animal model to study social anxiety disorder. Neuropsychopharmacology 2012;37:1433-1443.
16. PORSOLT RD, BERTIN A, JALFRE M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977;229:327-336.
17. CRYAN JF, MOMBEREAU C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004;9:326-357.
18. CRYAN JF, MOMBEREAU C, VASSOUT A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005;29:571-625.
19. PORSOLT RD, LENEGRE A. Behavioral models of depression. In Elliott J, Heal D, Marsden C editors Experimental approaches to anxiety and depression. London: Wiley, 1992; pp. 73-85.
20. KOTELEVTSEV Y, HOLMES MC, BURCHELL A et al. 11betahydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A 1997;94:14924-14929.